Abstract:Circadian clocks have been developed in evolution as an anticipatory mechanism allowing for adaptation to the constantly changing light environment due to rotation of the Earth. This mechanism is functional in all light-sensitive organisms. There is a considerable body of evidence on the tight connection between the circadian clock and most aspects of physiology and metabolism. Clocks, operative in the pancreatic islets, have caught particular attention in the last years due to recent reports on their critical roles in regulation of insulin secretion and etiology of type 2 diabetes. While β-cell clocks have been extensively studied during the last years, α-cell clocks and their role in islet function and orchestration of glucose metabolism stayed unexplored, largely due to the difficulty to isolate α-cells, which represents a considerable technical challenge. Here, we provide a detailed description of an experimental approach for the isolation of separate mouse α- and β-cell population, culture of isolated primary α- and β-cells, and their subsequent long-term high-resolution circadian bioluminescence recording. For this purpose, a triple reporter ProGlucagon-Venus/RIP-Cherry/Per2:Luciferase mouse line was established, carrying specific fluorescent reporters for α- and β-cells, and luciferase reporter for monitoring the molecular clockwork. Flow cytometry fluorescence-activated cell sorting allowed separating pure α- and β-cell populations from isolated islets. Experimental conditions, developed by us for the culture of functional primary mouse α- and β-cells for at least 10 days, will be highlighted. Importantly, temporal analysis of freshly isolated α- and β-cells around-the-clock revealed preserved rhythmicity of core clock genes expression. Finally, we describe the setting to assess circadian rhythm in cultured α- and β-cells synchronized in vitro. The here-described methodology allows to analyze the functional properties of primary α- and β-cells under physiological or pathophysiological conditions and to assess the islet cellular clock properties.

Corrigendum to “the CLOCK Protein Regulates Insulin Secretion Related with L-type Calcium Channels in Rat Pancreatic Beta Cells”

The CLOCK protein regulates insulin secretion related with L-type calcium channels in rat pancreatic beta cells

Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes

The Diurnal Rhythm of Insulin Receptor Substrate-1 (IRS-1) and Kir4.1 in Diabetes: Implications for a Clock Gene Bmal1

Insulin Post-Transcriptionally Modulates Bmal1 Protein to Affect the Hepatic Circadian Clock

In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis

Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein*

Circadian Metabolic Regulation Through Crosstalk Between Casein Kinase 1δ and Transcriptional Coactivator PGC-1α

Cryptochrome Mediates Circadian Regulation of Camp Signaling and Hepatic Gluconeogenesis

An Individual 12-H Shift of the Light-Dark Cycle Alters the Pancreatic and Duodenal Circadian Rhythm and Digestive Function

Calcium influx activates adenylyl cyclase 8 for sustained insulin secretion in rat pancreatic beta cells

The Circadian Protein CLOCK Regulates Cell Metabolism Via the Mitochondrial Carrier SLC25A10

High-Resolution Recording of the Circadian Oscillator in Primary Mouse α- and β-Cell Culture

Identification Of Pcbp1 As A Novel Modulator Of Mammalian Circadian Clock

Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein

A Cullin 4B-RING E3 Ligase Complex Fine-Tunes Pancreatic Δ Cell Paracrine Interactions.

Local and regional control of calcium dynamics in the pancreatic islet

Circadian modulation of glucose utilization via CRY1-mediated repression of Pdk1 expression

Advancements in research on the association between the biological CLOCK and type 2 diabetes

Phospho‑regulation of Cdc14A by polo‑like kinase 1 is involved in β‑cell function and cell cycle regulation.

IP6-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion